APLLTDNSEAlembic Pharmaceuticals Limited· PharmaceuticalsMediumNegative
Announced Mon, 4 May · 19:47 IST

Alembic Pharmaceuticals Limited has informed the Exchange about Resignation of Director/KMP/SMP

Management Changes View source PDF

APLLTD · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+2.4%1-day move
₹766.50
prior close
₹767.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.3+0.5-0.0+0.6+2.4+0.8+2.7+3.1-0.2+2.4-1.0-3.1+8.9
Up moveDown movePending
AI summary

Goldee Pardesi has resigned from the position of Associate Vice President - Sales & Marketing at Alembic Pharmaceuticals, effective 3rd February 2026. This is a senior management-level departure, not a Key Managerial Personnel or Board-level exit. Goldee cited personal and professional growth opportunities as the reason for leaving, and expressed commitment to ensuring a smooth transition. The company filed this intimation under the ResignationOfDirectorOrKeyManagerialPersonnelOrSeniorManagementPersonnel domain as per regulatory requirements.

Likely market impact

This resignation is unlikely to have any significant market impact as the AVP Sales & Marketing is a senior management role rather than a top-level executive. Shareholders should monitor for any successor announcement, particularly if the replacement affects sales strategy execution.